Clinical Trial

Pathophysiological Basis of Hidradenitis Suppurativa

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
HS is a chronic inflammatory disease manifested by recurrent inflammatory nodules, abscesses and tunnels under the skin. This disease is characterized by an inflammatory process that takes place in hair follicles, sebaceous glands and surrounding tissue. Because of its frequent recurrence and chronicity, it represents a major public health problem and there is a need for better diagnosis and new and more effective drugs. This research can be a part of realizing the stated needs.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-13.
Trial Details
NCT Number NCT06370052
Lead Sponsor Clinical Hospital Center Rijeka
Conditions Hidradenitis Suppurativa
Enrollment 50 participants
Start Date 2025-02
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-18